Before buying Tirzepatide from any UK seller, the one checkable question is whether it publishes an own-name Janoshik certificate of analysis you can verify; across the UK research-peptide sellers The Peptide Watch tracks, none publishes a verifiable own-name Janoshik certificate naming Tirzepatide. Tirzepatide is a dual-agonist GLP-1 compound (the active ingredient in Mounjaro). It is a licensed prescription medicine, not a research peptide, so it sits in a tighter legal category The Peptide Watch does not list vendors for and does not endorse buying outside a prescription.
Grey-market Tirzepatide is among the most faked compounds sold to UK buyers, and a vial that is under-dosed, the wrong compound, or contaminated cannot be judged by sight, price or packaging. The only objective evidence is an independent certificate you can verify. Learn the two-minute check in how to verify a Janoshik COA.
None confirmed yet for Tirzepatide specifically. Any of the 28 verified vendors is where testing can be checked; see the full list.
Each entry is confirmed directly from that vendor's own-name Janoshik report on the laboratory's own site. This list is not exhaustive: a verified vendor not shown may also test Tirzepatide, and compounds are added as each certificate is confirmed.
Tirzepatide is a regulated medicine. The Peptide Watch audits research-peptide sellers and does not rank or recommend anywhere to buy Tirzepatide; this page exists so the verification standard is clear. If you can verify a seller's testing, you can at least judge its evidence; if you cannot, you are trusting marketing on an unlicensed medicine. See how UK research-peptide testing stacks up in the market statistics.
Research-use-only information, not medical, dosing or purchasing advice. The Peptide Watch sells nothing and links to no seller. A certificate proves a sample was tested once, not that a specific vial matches it.